The US FDA is informing healthcare professionals of two recent cases of progressive multifocal leukoencephalopathy (PML) associated with Tysabri News item 26 February 2013 Pages: 2 - 2
Warning against unauthorised ephedrine and kava kava products Media release 26 February 2013 Pages: 2 - 2
Health Canada and Pfizer have agreed on an acceptable ethyl methanesulfonate limit for Viracept [nelfinavir] and the drug can now be used again Media release 26 February 2013 Pages: 2 - 2
The most frequently reported postmarketing adverse reactions associated with trastuzumab and rituximab were heart failure and WBC disorders, News item 26 February 2013 Pages: 3 - 3
Reflex sneezing appears to be associated with the use of periocular anaesthetic injection under IV sedation, News item 26 February 2013 Pages: 4 - 4
Qiagen has announced the EU launch of a new test for detecting adverse reactions to abacavir. Media release 26 February 2013 Pages: 4 - 4